FOCUS
C erviCal disc herniation (CDH) is a common cause of cervical radiculopathy. In a population-based study conducted in the US between 1976 and 1990, the annual age-adjusted incidence for CDH was 83.2 per 100,000. 24 A similar study was performed for 2000-2009, and showed an incidence of 1.79 per 1000 person-years. 30 Symptomatic CDH can be very debilitating and has an important impact on the patient's overall health status, causing loss of production. 4, 39 Surgical treatment of CDH is usually offered when conservative treatment fails after a minimum of 6 weeks of radiculopathy. 3 Anterior cervical discectomy (ACD) is the basic surgical treatment for patients with radicular pain caused by CDH. In 1958, Smith and Robinson first described anterior cervical decompression with the use of autologous iliac crest interbody graft (now known as anterior cervical discectomy and fusion [ACDF]). 32 They described ACDF as a treatment for degenerative spondylotic conditions. Beside eliminating painful motion and allowing decompression of the neural elements with enough stabilization of the affected spine segments, fusion was also offered as an opportunity to remove pathological processes such as infections, arthritis, or deformity.
For CDH, ACDF is accepted as standard surgical treatment for cervical radiculopathy with or without myelopathy. 5, 18 Although there is no clear evidence of the clinical benefits of fusion over no fusion, it has been reported that ACDF may cause adjacent-level disease (ALD), 10 often requiring reoperation or conservative treatment. 36, 37 Symptoms are similar to those of pseudarthrosis, with neck pain, radiating arm and shoulder pain, and stiffness of the neck. Abnormal loading stress on the adjacent levels due to fusion is hypothesized to cause ALD. 14, 31, 35 Another theory is that damage to the anterior longitudinal ligament or longus colli muscles during ACDF may cause ALD. 9 Artificial disc replacement, also known as total disc arthroplasty or cervical disc arthroplasty (CDA), is a less frequently performed technique to treat symptomatic CDH. During this procedure an artificial device is inserted between 2 vertebrae in the neck to replace the disc in the cervical spine. Several studies have already suggested that CDA may prevent ALD by preserving movement, 6, 38 and may even have a lower reoperation rate. 37 In 1966, Ulf Fernström was the first to describe the use of a device during a cervical discectomy. He inserted an intracorporal endoprosthesis shaped like a metal bearing into the disc space. 8, 13 Nowadays, there are many types of CDA devices approved by the US FDA: Mobi-C, the Prestige, the ProDisc-C, the Bryan Cervical Disc, the SE-CURE-C, and the PCM device. 2 The Mobi-C is the only device approved for both 1-and 2-level use. 1 Throughout the years, many studies comparing CDA and ACDF have been published, but most have had a short duration of follow-up. 15, 17, 25, 26, 34, 42 A recent meta-analysis of 8 randomized controlled trials (RCTs) with at least 48 months of follow-up showed that CDA was superior to ACDF based on arm pain, neck pain, functional improvement, neurological success, and rates of serious adverse events. 11 Although these studies suggested that CDA has advantages over ACDF, a clear consensus on this subject is still lacking. This may be one of the reasons for surgeons not to adopt CDA as a standard treatment for CDH. 37 This study aims to address the current use of CDA for CDH among an international group of spine surgeons.
Methods
A web-based survey (questionnaire) was sent to all members of AOSpine International by email using SurveyMonkey, Inc., on July 18, 2016. AOSpine is an international community of spine surgeons, orthopedic surgeons, neurosurgeons, academics, researchers, and other spine care professionals. At the time of this survey there were 6179 members. To improve the response rate, a single reminder was sent on August 18, 2016. The questionnaire consisted of 17 questions, starting with demographic and geographic information of the respondents. This was followed by different aspects of treatment: clinical aspects as indication for surgical treatment, standard technique used, and whether CDA is performed. If not, respondents were asked to rank the following reasons for not offering CDA: cost, complications, legal concerns, insurance issues, low concern for pseudarthrosis, and low evidence for benefit. Furthermore, respondents were asked for their expectations of treatment outcome and disadvantages of CDA, ACD, and ACDF. Last, opinions on the effect of patient or lifestyle factors on clinical outcomes were asked, including smoking, age, the ratio of preoperative neckpain and arm pain, body mass index, prescribing a cervical collar, and diabetes. No approval from the institutional review board was required, because no patients were involved.
Responses from residents and members not performing cervical disc surgery were excluded. Each question was analyzed separately and missing data were excluded from the analyses. All statistical analyses were performed using the Statistical Package for Social Sciences, version 21.0 for Windows (SPSS, Inc.). Mainly descriptive statistics were used to describe our results. A p value of < 0.05 was considered to be statistically significant.
Results
A total of 387 members, representing 67 countries, responded (response rate 6.3%) (Fig. 1) . Four respondents (2 residents, 1 surgeon not performing cervical discectomies, and 1 who answered with a blank questionnaire) were ex- cluded, leaving 383 respondents for analysis. Of these, 97.9% were male, and the surgeons had a mean of 15.0 ± 9.7 years of clinical experience (Table 1) . No difference in experience was observed between orthopedic and neurosurgeons (p = 0.620, t-test). Annually, the respondents perform an average of 34.7 ± 27.0 procedures for CDH. Cervical discectomy was more frequently performed by neurosurgeons than by orthopedic surgeons (41.5 ± 2.2 vs 29.5 ± 1.8, respectively; p = 0.038, t-test).
Pain medication and exercise therapy were expected to have the highest effectiveness on cervical radiculopathy, by 73% and 58% of the respondents, respectively (Fig. 2) . Holistic therapy and a collar were expected to give the lowest effectiveness, by 53.8% and 54.8% of the respondents, respectively. When offering surgery, the most important indications were failure of conservative treatment (95.2%) and the severity of pain and disability (94.8%) (Fig. 3) . The extent of the disc herniation as seen on MRI was considered to be the least important indication (12.2%). The majority of the surgeons (44.5%) regarded 4-8 weeks of radiculopathy as the optimal timing to perform surgery, whereas 19.7% operate earlier than 4 weeks and 35.8% operate later than 8 weeks.
An ACDF was the standard procedure for the majority (84.3%) of the surgeons (Table 2 ). 47.8% of the surgeons occasionally performed CDA, whereas 7.3% performed CDA as the standard approach for CDH. Other techniques (4.2%) performed as a standard procedure included posterior cervical discectomy, laminoplasty, and nucleoplasty. Among the CDA devices used, ProDisc-C was the most common (33.3%), followed by the Prestige (disc) LP (10.9%). Other (21.9%) less frequently applied devices included the ProDisc-C vivo, Active C, Dymicron, and Rotation.
Reasons for not offering CDA are shown in Fig. 4 . Low evidence for benefits of CDA over other surgical techniques and costs were the most important reasons for not offering CDA, by 33.2% and 29.6%, respectively. Legal concerns and insurance coverage were seen as the least important reasons. Table 3 shows that, compared with 
FIG. 2.
Graph showing expected effectiveness of conservative treatment modalities (numbers on the x-axis represent percents). GP = general practitioner.
ACD and ACDF, costs were considered to be the most important disadvantage of CDA (81.4%), followed by the risk of revision surgery (36.8%). The CDA procedure was expected to have a lower risk of ALD (54.4%), whereas ACDF was expected to have the highest risk (47.2%). Risk of spondylolisthesis was expected to be the smallest for ACDF by 77.3% of the respondents (Table 3) . Most surgeons were neutral on the risk of dysphagia for ACD, ACDF, or CDA. When comparing CDA with ACDF, preservation of motion of the neck was considered to be the biggest advantage of CDA (44.6%). Lower risk of ALD and a faster resumption of work and daily activities were other highly ranked advantages of CDA (Fig. 5) . When comparing ACD, ACDF, and CDA, 74.6% of the surgeons expected CDA to give the fastest rate of return to work and daily activities, whereas ACDF was rated the slowest (18.9%). The ACDF procedure was expected to have the highest effectiveness on arm pain (87.5%), followed by CDA (77.9%), whereas ACD was rated the least effective (12.6%). Postoperative neck pain was expected to be the highest after ACD (34.4%) and the lowest after CDA (37.8%). However, CDA was also expected to give the highest complication risk (28.0%). The ACD procedure was believed to have the highest risk for revision surgery (50.3%), whereas ACDF was believed to have the lowest risk for revision surgery (53.5%) ( Table 4) . Figure 6 gives an overview of prognostic factors on clinical outcomes after surgery. Patients whose arm pain was greater than their neck pain were considered to have the best outcome (91.6%). Other important factors were nonsmoking and age < 70 years. A postoperative collar was expected to have the least effect on outcome (45.3%).
Discussion
This survey among 383 international spine surgeons shows that CDA is not widely accepted as the standard treatment of CDH, and that ACDF is still the procedure of choice among the majority of the responding surgeons when conservative treatment like pain medication and exercise therapy fails for more than 4-8 weeks. Low evidence for benefits and higher costs were the most important reasons for not offering CDA. The reported advantages of CDA included lower risk of ALD and preservation of motion of the neck. Among the CDA devices used, ProDisc-C was by far the one most applied.
Because cervical radiculopathy is self-limiting, most patients do not require surgery. There is limited evidence on the nonoperative management of cervical radiculopathy. According to our survey, pain medication is expected to have the highest effectiveness, followed by exercise therapy. Although the use of pain medication such as nonsteroidal antiinflammatory drugs for treating cervical radiculopathy has not been studied extensively yet, the effec- 
FIG. 3. Graph showing indications for CDH surgery (numbers on the x-axis represent percents).
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tive use of pain medication for lumbar radiculopathy suggest that it might also be beneficial for cervical radiculopathy. 7 Exercise therapy such as manual therapy may provide short-term benefit for neck pain and radicular symptoms, but can also cause spinal cord injury, myelopathy, or even worsening of the symptoms. 16, 27 In combination with the lack of high-quality evidence on the effectiveness of manual therapy, it is not recommended as treatment for cervical radiculopathy. 7 The CDA was adopted as the standard procedure by only 7.3% of the surgeons. Reasons for not offering CDA were costs and lack of evidence on its benefits. In 2016, de Rooij et al. published a survey among Dutch neurosurgeons. 5 They observed that despite the lack of solid evidence, ACDF is still the preferred technique to treat CDH. In this Dutch survey, 47.9% of the surgeons considered a minimum of 8-12 weeks of radiculopathy as the optimal timing to perform surgery, whereas in the present international survey 44.5% of the surgeons considered 4-8 weeks as the optimal timing to perform CDH surgery. Differences may be explained by national and international guidelines and recommendations. To the best of our knowledge no high-quality studies are available considering timing of operation. In the Dutch guideline, 2 months of conservative treatment is recommended, 21 whereas Carette and Fehlings suggest conservative treatment for 6-12 weeks. 3 Advantages of CDA were lower risk of ALD and preservation of motion of the neck. However, only 7.3% of the surgeons adopted CDA as standard treatment for CDH, mainly due to higher costs and low evidence for benefits. Recent studies have shown significant superior postoperative outcomes in neck functionality, neck pain score, arm pain score, and quality of life for CDA compared with ACDF. 29, 37 A recent meta-analysis of trials comparing CDA with ACDF showed that the risk of ALD was lower in patients treated with CDA. Moreover, it showed that CDA was associated with fewer adverse events, fewer reoperations, and better neurological success. These findings suggest that CDA is a good alternative for ACDF. However, due to different follow-up times, nonblinded study design, and poor heterogeneity of the results, this meta-analysis should be interpreted with caution. 37 Zhong et al. showed in a recent study that CDA is also correlated with a lower risk for reoperation compared with ACDF, making it a safe and effective alternative for treat-
FIG. 4.
Graphs showing reasons for not offering CDA (numbers on the y-axes represent percents), ranking from 1 as the most important to 6 as the least important (x-axes). ing CDH. 42 Yu et al. also found that CDA had a significantly lower overall reoperation rate than ACDF. 40 Reasons for revision surgery are plate subsidence, plate lift-off causing dysphagia, and additional fusion at adjacent levels. In most cases, ALD and pseudarthrosis were the main reasons for reoperation. 19 A CDA was expected to solve the ALD problem by preserving movement in the affected levels after discectomy. 2, 6 Dysphagia is a common complication after anterior cervical spine surgery, and can occur in up to 71% of ACDF cases. 28 However, the majority of the cases are transient and symptoms will disappear 12 weeks after surgery. Most respondents were neutral on whether ACD, ACDF, or CDA would have a higher risk for dysphagia. A pooled analysis consisting of 1512 patients who underwent CDA and 1199 patients who underwent ACDF showed that the incidence of dysphagia after CDA was significantly lower than after ACDF (9.46% vs 12.09%, respectively). 41 Whether a difference in incidence of 2.63% for a usually self-limiting complication such as dysphagia is clinically relevant remains subject to debate.
Among the CDA devices used, ProDisc-C was by far the most frequently chosen. In an RCT study of 209 patients who were randomized into a ProDisc-C group and an ACDF group, greater success after 6 months of follow-up was seen in the ProDisc-C group when comparing neurological success. 19 Neurological success was defined as the maintenance of or improvement in results of neurological evaluations, including sensory, motor, and reflex functions. At 24 months of follow-up the difference in neurological success was not significant anymore. Also, the ProDisc-C group showed a significant improvement of the Neck Disability Index during follow-up. This is in accordance with the study of Yu et al., in which patients treated with CDA showed a significantly greater improvement in neck functionality, neck pain, and arm pain. 40 According to the surgeons in this survey, a collar was expected to have the lowest effectiveness, whereas exercise therapy was expected to give the highest effectiveness after pain medication. In 2009, Kuijper et al. conducted an RCT in which 205 patients with recent-onset cervical radiculopathy were randomized between treatment with a semihard collar and taking rest for 3-6 weeks, twiceweekly sessions of physiotherapy for 6 weeks, or a waitand-see policy without a specific treatment. 12 They showed that after 6 weeks of treatment with physical therapy or a collar, patients had a significantly faster reduction of neck and arm pain than those in the control group. An explanation for this difference between the evidence and the expectations of the surgeons for prescribing a collar preoperatively could be the difference in the population of the study and the population that the surgeons see in practice. The patients included in the trial of Kuijper et al. were only included when the radiculopathy was present for less than 1 month, whereas patients usually get referred to surgeons after a period of conservative treatment. However, paradoxically 19.7% of the surgeons in this survey claimed that the optimal time to perform surgery for CDH is after less than 4 weeks of radiculopathy, suggesting that a portion of these procedures could have been prevented with conservative treatment.
Cost is considered to be one of the most important reasons for not offering CDA according to our survey. In 2013 a study was conducted on the cost-effectiveness of CDA versus ACDF. 22 In this study, the incremental cost-effectiveness ratio was used to summarize the cost-effectiveness, which is defined by the difference in cost between CDA and ACDF, divided by the difference in effectiveness. In this study the incremental cost-effectiveness ratio was $2394 per quality-adjusted life year. This is lower than the commonly accepted threshold of $50,000 per qualityadjusted life year, making CDA cost-effective. However, another study concluded that in order for CDA to be more cost-effective than ACDF, the device must function for at least 14 years. 22 Furthermore, a retrospective matched cohort analysis of a national claims database consisting of 6635 patients who underwent ACDF and 327 patients who received CDA concluded that CDA resulted in lower total costs than ACDF at the time the first procedure was performed and after 24 months of follow-up. 23 In this study the monthly cost of care was analyzed as well, and even so CDA was more effective in reducing the costs compared with ACDF.
The role of different conservative treatment modalities and the optimal timing of surgery for CDH are areas for further research. Failure of conservative treatment and the severity of pain and disability were seen as the most important indications for surgery. Further studies should also assess whether these subgroups of patients would benefit more from surgery than others. Our findings show that the cost of CDA plays a big role in whether to offer it. To our knowledge, no high-quality research on the implementation of CDA in surgical practice or the cost-effectiveness from society's perspective have been conducted. These studies should establish whether CDA, during and after a surgeon's learning curve, is superior to ACDF in terms of clinical outcomes, complication and reoperation rates, and cost-effectiveness in both the short and long term. This study also has some limitations that have to be discussed. Surgeons performing CDA may be more prone to react positively due to their own belief and self-convincing experiences. However, the percentage of surgeons performing CDA as a first treatment option for symptomatic CDH was low. Furthermore, recommendations and clinical guidelines may differ between professional societies on the international and national level, and thus our results may only be applicable to the respondents in this survey. Finally, we limited the responders by only asking closed questions. Strengths include an international group of respondents representing all continents, with clinical experience ranging from 0 to 50 years. The response rate of 6.3% is another limitation. However, the response rate of this study is comparable to other surveys conducted among AOSpine members. 20, 33 Furthermore, only surgeons performing cervical disc surgery were eligible, so not all 6179 members could participate in this survey. Thus the response rate in fact should be higher than was calculated.
Conclusions
In this survey, CDA is not considered to be the standard treatment for CDH, even though CDA was expected to reduce the risk of ALD and give the fastest recovery. The cost of CDA plays a big role in whether to offer it. More research on the implementation impact of CDA and the cost-effectiveness from society's perspective should be conducted.
